Surgical Management of BPH Webcast (2021)

Surgical Management of BPH is an exciting new educational initiative featuring a series of four interactive, case-based, live virtual courses conducted in English, Spanish, Portuguese, and French.  For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentation and discussion.  Semi-live surgical videos will be utilized to demonstrate and emphasize the significant elements of various BPH procedures.

Based on the documented need from the 2020 AUA BPH global needs assessment, the AUA has produced this new series of educational offerings for the urologic care team focused on the newest technology and procedures for the surgical management of BPH. Each activity will be recorded and posted on AUA's YouTube channel. Additionally, the English course will be available in webcast format on AUAUniversity.  The Spanish course will be available as a webcast and hosted on AUAUniversity’s microsite featuring Spanish content. Learners will also be provided with links to access additional resources including the AUA’s clinical guidelines discussed during the virtual courses and associated patient resources.   

As an additional resource, AUA recommends listening to the pilot activity in this series available as an episode on AUA’s podcast channel. The podcast focused on surgical management of BPH, features an interview with world-renowned BPH surgeons.



This educational series is supported by independent educational grants from:

  • Olympus Corporation of the Americas
  • Teleflex

Target Audience

  • Urologists
  • Residents

Learning Objectives

At the conclusion of this activity, participants will be able to: 

  1. Describe the role of the AUA Clinical Guidelines for the Surgical Management BPH.
  2. Discuss the evidence base for current technologies, including pivotal studies, and be able to define the role and clinical expectation for each of them.
  3. Interpret the current clinical results and compare the patient experiences of these treatments in relation to more established and even abandoned treatments for patient groups with similar characteristics.
  4. Differentiate between each of the new technologies for treating BPH/LUTS based on both their mode-of-action and the quality of their supporting evidence.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
Course expires: 

Education Council Disclosures

 Education Council Disclosures 2021

COI Review Work Group Disclosures

PDF icon COI Review Work Group Disclosures 2021

All relevant financial relationships have been mitigated. 

AUA Office of Education Staff has nothing to disclose.


Learners will participate in this online educational activity by viewing the webcast, completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy, and submit the program evaluation.

Estimated time to complete this activity: 2.00 hours

Release Date: July, 2021
Expiration Date: July, 2022


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Please login or register to take this course.